Startseite Supportive Therapy of the Sepsis Syndrome
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Supportive Therapy of the Sepsis Syndrome

  • Andreas Meier-Hellmann , Samir Sakka und Konrad Reinhart
Veröffentlicht/Copyright: 1. Juni 2005
Veröffentlichen auch Sie bei De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
Aus der Zeitschrift Band 37 Heft 3

Abstract

Adequate volume loading may be the most important step in the treatment of patients with septic shock. Techniques allowing us to achieve and tightly control volume loading and regional perfusion are considered to be helpful. An elevated oxygen delivery may be beneficial in some patients but the increase of oxygen delivery should be guided by the measurement of parameters assessing global and regional oxygenation. Forcing an increase in oxygen delivery by the use of very high dosages of catecholamines can be harmful. Vasopressors should be used for achieving an adequate perfusion pressure. For norepinephrine, no negative effects on regional perfusion have been demonstrated. Epinephrine and dopamine should be avoided because they seem to redistribute blood flow away from the splanchnic region. There are no convincing data yet to support the routine use of low dose dopamine or dopexamine in patients with sepsis. Neither low dose dopamine nor dopexamine has been proven to prevent renal failure in septic patients. Furthermore, there is evidence that low dose dopamine may reduce mucosal perfusion in the gut in some patients. There is some suggestion that dopexamine can improve splanchnic perfusion but since these effects remain somewhat controversial, there is no reason for a general recommendation for dopexamine in septic patients.

:
Published Online: 2005-06-01
Published in Print: 1999-03-01

Copyright (c)1999 by Walter de Gruyter GmbH & Co. KG

Artikel in diesem Heft

  1. IFCC/Beckman European Conference 1998 Frontiers in Molecular Basis of Disease: Inflammatory Diseases
  2. Frontiers in Molecular Basis of Disease: Inflammatory Diseases
  3. Mechanisms of Antigen Presentation
  4. How to Extinguish Lymphocyte Activation, Immunotyrosine-Based Inhibition Motif (ITIM)-Bearing Molecules a Solution?
  5. Association between Reduced Human Leukocyte Antigen (HLA)-DR Expression on Blood Monocytes and Increased Plasma Level of Interleukin-10 in Patients with Severe Burns
  6. Immunostimulatory CpG Motifs Trigger a T Helper-1 Immune Response to Human Immunodeficiency Virus Type-1 (HIV-1) gp160 Envelope Proteins
  7. Activation and Regulation of NFκB during Acute Inflammation
  8. CD 14++ Monocytes, CD14+/CD16+ Subset and Soluble CD14 as Biological Markers of Inflammatory Systemic Diseases and Monitoring Immuno-suppressive Therapy
  9. A Potential Role of an Intracellular Signaling Defect in Neutrophil Functional Abnormalities and Promotion of Tissue Damage in Patients with Localized Juvenile Periodontitis
  10. Polymorphonuclear Oxidative Burst after Helicobacter pylori Water Extract Stimulation Is not Influenced by the Cytotoxic Genotype but Indicates Infection and Gastritis Grade
  11. Flow Cytometry of Cerebrospinal Fluid (CSF) Lymphocytes: Alterations of Blood/CSF Ratios of Lymphocyte Subsets in Inflammation Disorders of Human Central Nervous System (CNS)
  12. Effects of Oxidized Low Density Lipoprotein, Lipid Mediators and Statins on Vascular Cell Interactions
  13. Mycophenolic Acid Influences T Helper 2 (Th2) Cytokine Induced Expression of Intercellular Cell Adhesion Molecule -1 (ICAM-1) on Human Endothelial Cells
  14. Alterations of Endothelial Nucleotide Levels by Mycophenolic Acid Result in Changes of Membrane Glycosylation and E-Selectin Expression
  15. C-Reactive Protein: Structural Biology and Host Defense Function
  16. A Novel Acute-Phase Marker: Lipopolysaccharide Binding Protein (LBP)
  17. Detection of Acute Phase Response and Infection. The Role of Procalcitonin and C-Reactive Protein
  18. Lactoferrin: A Multifunctional Glycoprotein Involved in the Modulation of the Inflammatory Process
  19. Annexin V and Phospholipid Metabolism
  20. Regulation of Leukocyte Trafficking by Lipoxins
  21. Lipoxin and Aspirin-Triggered 15-epi-Lipoxin Cellular Interactions Anti-Inflammatory Lipid Mediators
  22. Differentiation and Assessment of Cell Death
  23. Depending on Their Concentration Oxidized Low Density Lipoproteins Stimulate Extracellular Matrix Synthesis or Induce Apoptosis in Human Coronary Artery Smooth Muscle Cells
  24. Apheresis of Plasma Compounds as a Therapeutic Principle in Severe Sepsis and Multiorgan Dysfunction Syndrome
  25. Supportive Therapy of the Sepsis Syndrome
  26. Supplemental Immune Globulins in Sepsis
  27. Polymorphonuclear Granulocyte Stimulation by Cellulose-Based Hemodialysis Membranes
  28. Reduction of Circulating Cholesterol and Apolipoprotein Levels during Sepsis
  29. Outcome Prediction by Traditional and New Markers of Inflammation in Patients with Sepsis
  30. Isolation of Highly Enriched Human Monocytes from Ten ml Samples of Heparinised Whole Blood
  31. Endotoxin Adsorbant Based on Immobilized Human Serum Albumin
Heruntergeladen am 7.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.1999.056/pdf
Button zum nach oben scrollen